Venous thromboembolism during pregnancy: A retrospective study of enoxaparin safety in 624 pregnancies

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 11, 2001, Pages 1134-1140

  Lepercq, Jacques ^a   Conard, Jacqueline ^b   Borel Derlon, Annie ^c   Darmon, Jean Yves ^d   Boudignat, Odile ^d   Francoual, Christine ^a   Priollet, Pascal ^e   Cohen, Corinne ^d   Yvelin, Nicole ^d   Schved, Jean François ^f   Tournaire, Michel ^a   Borg, Jeanne Yvonne ^g  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b HÔTEL DIEU   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d SANOFI   (France)

^e SAINT JOSEPH HOSPITAL   (France)

^f HÔPITAL SAINT ELOI   (France)

^g HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONGENITAL DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HIGH RISK POPULATION; HUMAN; MATERNAL TREATMENT; MORBIDITY; MULTICENTER STUDY; NEWBORN HEMORRHAGIC DISEASE; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STILLBIRTH; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 0035160309     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(01)00272-8     Document Type: Article

References (26)

1. Thromboembolic disease associated with pregnancy: An 11-year review
2. Prevention of venous thrombosis and pulmonary embolism
3. Inherited thrombophilia: Part 2
4. Use of antithrombotic agents during pregnancy. Fifth American College of Chest Physicians (ACCP) on Antithrombotic Therapy
5. Risks to the fetus of anticoagulant therapy during pregnancy
6. Heparin therapy during pregnancy: Risks to the fetus and mother
7. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety
8. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
9. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications for coumarin
10. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound
11. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy
12. Safety of low-molecular-weight heparin in pregnancy: A systematic review
13. Antenatal use of enoxaparin for prevention and treatment of thromboembolism during pregnancy
14. Fetal growth from the AUDIPOG study. I. Establishment of reference curves
15. The perinatal situation in France. Trends between 1981 and 1995
16. Increased frequency of genetic thrombophilia in women with complications of pregnancy
17. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
18. Intracranial hemorrhage: Germinal matrix-intraventricular hemorrhage of the premature infant
19. Drugs in pregnancy
20. Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
21. Low molecular weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies
22. Puerperal thromboprophylaxis: Comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
23. Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin